Sequel Med Tech and Abbott to Integrate Future Glucose-Ketone Sensor with twiist™ AID System

Automated Insulin Delivery System to Be Integrated with Glucose-Ketone Sensor

Insulin delivery technology company Sequel Med Tech announced its future partnership with Abbott’s glucose-ketone sensor, which is currently under development.

Sequel to pair twiist with Abbott's future dual glucose-ketone sensor

The twiist system (left) and FreeStyle Libre 3 system (right). [Images courtesy of Sequel Med Tech and Abbott]Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott sensor. The companies agreed to pair twiist, powered by Tidepool, with Abbott‘s glucose-ketone sensor, currently under development. Sequel said the agreement aims to improve outcomes for people with type 1 diabete…

Sequel Med Tech and Abbott to Integrate Future Glucose-Ketone Sensor with twiist™ AID System

What You Should Know:  – Sequel Med Tech, a company developing state-of-the-art insulin delivery technologies, announced a commercial development agreement with Abbott.  – The collaboration aims for the future integration of Sequel’s twiist Automated Insulin Delivery (AID) System, powered by Tidepool, with Abbott’s glucose-ketone sensor, which is currently under development. – The planned integration is designed to significantly improve outcomes…